Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-08

Clinical Trial Update: Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children [Phase 1]

View source ↗

Summary

Phase 1b trial update for PVSRIPO in recurrent malignant glioma in children has completed enrollment and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PVSRIPO

Snippet

Sponsor: Istari Oncology, Inc. | Conditions: Malignant Glioma, Anaplastic Astrocytoma | Phase 1 | Status: COMPLETED | Results posted: 2024-04-08